Angela Walsh's most recent trade in Dogwood Therapeutics Inc. was a trade of 12,075 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics Inc. | Angela Walsh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 12,075 | 12,075 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Walsh Angela | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 63,618 | 63,618 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Angela Walsh | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Angela Walsh | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Angela Walsh | SVP OF FINANCE | Purchase of securities on an exchange or from another person at price $ 4.58 per share. | 23 May 2022 | 2,000 | 3,000 | - | 4.6 | 9,150 | Common Stock |
| Dogwood Therapeutics Inc. | Angela Walsh | SVP OF FINANCE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Angela Walsh | VP of Finance | Purchase of securities on an exchange or from another person at price $ 7.30 per share. | 28 Jan 2021 | 1,000 | 1,000 | - | 7.3 | 7,300 | Common Stock |
| Dogwood Therapeutics Inc. | Angela Walsh | VP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 209 | 41,621 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Angela Walsh | VP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 41,412 | 41,412 | - | - | Stock Option (right to buy) |